Contraception in the setting of obesity and bariatric surgery

Katharine Simmons, Alison Edelman

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Until recently, contraceptive research has generally excluded women over 130 % of ideal body weight. Given the dramatic increase in obesity worldwide, it has become a public health necessity to address the use and safety of contraception in obese women. Current research on contraceptive efficacy and safety in obese women is overall reassuring, and most contraceptives are given a category 1 rating (no restriction) for obesity by major regulatory agencies such as the World Health Organization. Likewise, women with a history of bariatric surgery are eligible for most methods of contraception without restriction. Like all women, obese women wishing to avoid pregnancy should be encouraged to use the best methods for preventing pregnancy, either long-acting reversible or permanent methods. Providers should feel reassured in offering obese women a range of contraceptive options, without expectation of increased side effects or weight gain. This chapter reviews data on the efficacy, pharmacokinetics, and safety of modern methods of contraception in obese women, and in women undergoing bariatric surgery. We also address the effect of these contraceptive methods on lipid profiles.

Original languageEnglish (US)
Title of host publicationContraception for the Medically Challenging Patient
PublisherSpringer New York
Pages157-180
Number of pages24
ISBN (Print)9781493912339, 9781493912322
DOIs
StatePublished - Jan 1 2014

Fingerprint

Bariatric Surgery
Contraception
Obesity
Contraceptive Agents
Safety
Ideal Body Weight
Pregnancy
Research
Weight Gain
Pharmacokinetics
Public Health
Lipids

ASJC Scopus subject areas

  • Health Professions(all)
  • Medicine(all)

Cite this

Simmons, K., & Edelman, A. (2014). Contraception in the setting of obesity and bariatric surgery. In Contraception for the Medically Challenging Patient (pp. 157-180). Springer New York. https://doi.org/10.1007/978-1-4939-1233-9_10

Contraception in the setting of obesity and bariatric surgery. / Simmons, Katharine; Edelman, Alison.

Contraception for the Medically Challenging Patient. Springer New York, 2014. p. 157-180.

Research output: Chapter in Book/Report/Conference proceedingChapter

Simmons, K & Edelman, A 2014, Contraception in the setting of obesity and bariatric surgery. in Contraception for the Medically Challenging Patient. Springer New York, pp. 157-180. https://doi.org/10.1007/978-1-4939-1233-9_10
Simmons K, Edelman A. Contraception in the setting of obesity and bariatric surgery. In Contraception for the Medically Challenging Patient. Springer New York. 2014. p. 157-180 https://doi.org/10.1007/978-1-4939-1233-9_10
Simmons, Katharine ; Edelman, Alison. / Contraception in the setting of obesity and bariatric surgery. Contraception for the Medically Challenging Patient. Springer New York, 2014. pp. 157-180
@inbook{ca1cdcaf13714e6daf8ce8c43d0570f3,
title = "Contraception in the setting of obesity and bariatric surgery",
abstract = "Until recently, contraceptive research has generally excluded women over 130 {\%} of ideal body weight. Given the dramatic increase in obesity worldwide, it has become a public health necessity to address the use and safety of contraception in obese women. Current research on contraceptive efficacy and safety in obese women is overall reassuring, and most contraceptives are given a category 1 rating (no restriction) for obesity by major regulatory agencies such as the World Health Organization. Likewise, women with a history of bariatric surgery are eligible for most methods of contraception without restriction. Like all women, obese women wishing to avoid pregnancy should be encouraged to use the best methods for preventing pregnancy, either long-acting reversible or permanent methods. Providers should feel reassured in offering obese women a range of contraceptive options, without expectation of increased side effects or weight gain. This chapter reviews data on the efficacy, pharmacokinetics, and safety of modern methods of contraception in obese women, and in women undergoing bariatric surgery. We also address the effect of these contraceptive methods on lipid profiles.",
author = "Katharine Simmons and Alison Edelman",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-1233-9_10",
language = "English (US)",
isbn = "9781493912339",
pages = "157--180",
booktitle = "Contraception for the Medically Challenging Patient",
publisher = "Springer New York",

}

TY - CHAP

T1 - Contraception in the setting of obesity and bariatric surgery

AU - Simmons, Katharine

AU - Edelman, Alison

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Until recently, contraceptive research has generally excluded women over 130 % of ideal body weight. Given the dramatic increase in obesity worldwide, it has become a public health necessity to address the use and safety of contraception in obese women. Current research on contraceptive efficacy and safety in obese women is overall reassuring, and most contraceptives are given a category 1 rating (no restriction) for obesity by major regulatory agencies such as the World Health Organization. Likewise, women with a history of bariatric surgery are eligible for most methods of contraception without restriction. Like all women, obese women wishing to avoid pregnancy should be encouraged to use the best methods for preventing pregnancy, either long-acting reversible or permanent methods. Providers should feel reassured in offering obese women a range of contraceptive options, without expectation of increased side effects or weight gain. This chapter reviews data on the efficacy, pharmacokinetics, and safety of modern methods of contraception in obese women, and in women undergoing bariatric surgery. We also address the effect of these contraceptive methods on lipid profiles.

AB - Until recently, contraceptive research has generally excluded women over 130 % of ideal body weight. Given the dramatic increase in obesity worldwide, it has become a public health necessity to address the use and safety of contraception in obese women. Current research on contraceptive efficacy and safety in obese women is overall reassuring, and most contraceptives are given a category 1 rating (no restriction) for obesity by major regulatory agencies such as the World Health Organization. Likewise, women with a history of bariatric surgery are eligible for most methods of contraception without restriction. Like all women, obese women wishing to avoid pregnancy should be encouraged to use the best methods for preventing pregnancy, either long-acting reversible or permanent methods. Providers should feel reassured in offering obese women a range of contraceptive options, without expectation of increased side effects or weight gain. This chapter reviews data on the efficacy, pharmacokinetics, and safety of modern methods of contraception in obese women, and in women undergoing bariatric surgery. We also address the effect of these contraceptive methods on lipid profiles.

UR - http://www.scopus.com/inward/record.url?scp=84956716244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956716244&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1233-9_10

DO - 10.1007/978-1-4939-1233-9_10

M3 - Chapter

SN - 9781493912339

SN - 9781493912322

SP - 157

EP - 180

BT - Contraception for the Medically Challenging Patient

PB - Springer New York

ER -